New Key Statistics Module, Z-Score and F-Score
TSX:MBX Key Ratios
Market Cap C$ M | 44.66 |
Enterprise Value C$ M | 38.50 |
P/E(ttm) | 10.83 |
PE Ratio without NRI | 10.83 |
Forward PE Ratio | 16.50 |
Price/Book | 1.61 |
Price/Sales | 1.89 |
Price/Free Cash Flow | 25.00 |
Price/Owner Earnings | 12.50 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 23.00 |
EPS (TTM) C$ | 0.03 |
Beneish M-Score | -1.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 542.90 |
EV-to-EBIT | 7.75 |
EV-to-EBITDA | 6.05 |
PEG | -- |
Shares Outstanding M | 137.42 |
Net Margin (%) | 17.04 |
Operating Margin % | 5.75 |
Pre-tax Margin (%) | 17.04 |
Quick Ratio | 4.98 |
Current Ratio | 6.64 |
ROA % (ttm) | 11.42 |
ROE % (ttm) | 16.16 |
ROIC % (ttm) | 6.51 |
Dividend Yield % | -- |
Altman Z-Score | 3.10 |
TSX:MBX Number of Guru Trades
TSX:MBX Volume of Guru Trades
Gurus Latest Trades with TSX:MBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:MBX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Microbix Biosystems Inc Insider Transactions
No Available Data